User profiles for M. Dugas

Michel J. Dugas

- Verified email at uqo.ca - Cited by 24679

Martin Dugas

- Verified email at med.uni-heidelberg.de - Cited by 22085

Electronic health records: new opportunities for clinical research

…, B Claerhout, C Daniel, M Dugas… - Journal of internal …, 2013 - Wiley Online Library
Clinical research is on the threshold of a new era in which electronic health records ( EHR s)
are gaining an important novel supporting role. Whilst EHR s used for routine clinical care …

Evidence-based strategies for implementing guidelines in obstetrics: a systematic review

N Chaillet, E Dubé, M Dugas, F Audibert… - Obstetrics & …, 2006 - journals.lww.com
OBJECTIVE: To estimate effective strategies for implementing clinical practice guidelines in
obstetric care and to identify specific barriers to behavior change and facilitators in obstetrics…

Cognitive-behavioral treatment for generalized anxiety disorder: Current status and future directions

MJ Dugas, N Koerner - Journal of Cognitive Psychotherapy, 2005 - search.proquest.com
… In this article and in earlier accounts of our GAD model and treatment (see Dugas & Ladouceur,
1998), we conceptualize worry as an approach-avoidance conflict. This formulation has …

[HTML][HTML] Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

…, K Chiba, H Tanaka, HP Koeffler, HU Klein, M Dugas… - Leukemia, 2014 - nature.com
High-throughput DNA sequencing significantly contributed to diagnosis and prognostication
in patients with myelodysplastic syndromes (MDS). We determined the biological and …

Experimental manipulation of intolerance of uncertainty: A study of a theoretical model of worry

R Ladouceur, P Gosselin, MJ Dugas - Behaviour research and therapy, 2000 - Elsevier
Intolerance of uncertainty has been identified as an important variable related to worry and
Generalized Anxiety Disorder (GAD) [Dugas, MJ, Gagnon, F., Ladouceur, R., & Freeston, MH (…

Why do people worry?

MH Freeston, J Rhéaume, H Letarte, MJ Dugas… - Personality and …, 1994 - Elsevier
… Studies on the French adaptation show excellent internal consistency, good test-retest
reliability, and preliminary evidence of validity (Dugas et ul., in press). The Beck Anxiety InventoF …

Generalized anxiety disorder: A preliminary test of a conceptual model

MJ Dugas, F Gagnon, R Ladouceur… - Behaviour research and …, 1998 - Elsevier
This study presents a preliminary test of a conceptual model of Generalized Anxiety Disorder
(GAD) which is theoretically driven and has clear clinical implications. The model's main …

The intolerance of uncertainty scale: Psychometric properties of the English version

K Buhr, MJ Dugas - Behaviour research and therapy, 2002 - Elsevier
… who met the criteria for GAD by questionnaire (M=70.51, SD=12.56) scored significantly
higher on the IUS than those who met only the somatic criteria (M=57.12, SD=17.83), the latter …

Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine

…, A Doctor, A Davis, J Duff, MA Dugas… - Critical care …, 2009 - journals.lww.com
… Titration of therapy to CO 3.3–6.0 L/min/m 2 remains the goal in patients with persistent
catecholamine resistant shock in 2007 guidelines. Doppler echocardiography can also be used …

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and …

S Schnittger, C Schoch, M Dugas… - Blood, The Journal …, 2002 - ashpublications.org
FLT3 length mutation (FLT3-LM) is a molecular marker potentially useful for the characterization
of acute myeloid leukemia (AML). To evaluate the distribution of FLT3-LM within biologic …